Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer’s Disease
Molecules - Switzerland
doi 10.3390/molecules23102540
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 5, 2018
Authors
Publisher
MDPI AG